VANIQA Drug Patent Profile
✉ Email this page to a colleague
When do Vaniqa patents expire, and when can generic versions of Vaniqa launch?
Vaniqa is a drug marketed by Skinmedica and is included in one NDA.
The generic ingredient in VANIQA is eflornithine hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the eflornithine hydrochloride profile page.
Summary for VANIQA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Clinical Trials: | 3 |
Patent Applications: | 4,519 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VANIQA |
What excipients (inactive ingredients) are in VANIQA? | VANIQA excipients list |
DailyMed Link: | VANIQA at DailyMed |
Recent Clinical Trials for VANIQA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Children's Oncology Group | Phase 2 |
Bispebjerg Hospital | Phase 4 |
National Cancer Institute (NCI) | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for VANIQA
US Patents and Regulatory Information for VANIQA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Skinmedica | VANIQA | eflornithine hydrochloride | CREAM;TOPICAL | 021145-001 | Jul 27, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VANIQA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Skinmedica | VANIQA | eflornithine hydrochloride | CREAM;TOPICAL | 021145-001 | Jul 27, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
Skinmedica | VANIQA | eflornithine hydrochloride | CREAM;TOPICAL | 021145-001 | Jul 27, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
Skinmedica | VANIQA | eflornithine hydrochloride | CREAM;TOPICAL | 021145-001 | Jul 27, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VANIQA
See the table below for patents covering VANIQA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 9421216 | ⤷ Try a Trial | |
Japan | S5419913 | ALPHAAHALOMETHYL DERIVATIVE OF ALPHAAAMINO ACID | ⤷ Try a Trial |
Israel | 109536 | STABLE TOPICAL COMPOSITIONS FOR INHIBITING HAIR GROWTH | ⤷ Try a Trial |
Italy | 1105099 | DERIVATI ALFA-ALOGENOMETILICI DI ALFA-AMMINOACIDI E RELATIVO PROCEDIMENTO DI PRODUZIONE | ⤷ Try a Trial |
Russian Federation | 2139705 | COMPOSITION FOR TOPICAL USE FOR INHIBITION OF HAIR GROWTH AND METHOD OF INHIBITION OF HAIR GROWTH | ⤷ Try a Trial |
Denmark | 0689416 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |